Biotech

All Articles

' Scientific intuition' led FDA experts to support Zevra's rare condition med

.Zevra Rehabs' uncommon condition medication appears to become on the course to authorization this a...

Pfizer takes $230M hit after axing stopped working DMD genetics treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics therapy failing has gone a $230 millio...

AC Immune finds 'landmark' prospective in Alzheimer's medicine data

.After more than 20 years of service neurodegenerative health conditions, Swiss biotech a/c Invulner...

GSK drops ph. 2 HPV injection over shortage of best-in-class prospective

.GSK has actually ditched a period 2 human papillomavirus (HPV) injection from its own pipeline afte...

OS Treatments refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.OS Therapies will definitely list on the NYSE American inventory exchange today via a $6.4 thousand...

ALX's fizzling CD47 feedback cost delivers sell spiraling down

.ALX Oncology's period 2 gastric cancer cells response rate has actually damaged. After observing it...

Ionis axes eye ailment from aim ats of Roche-partnered prospect after information dissatisfy

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of assu...

Biogen's chief executive officer mentioned no high-risk deals in 2023. He prepares to become daring

.While Biogen's pharma peers are looking for late-stage properties along with little danger, CEO Chr...

Instil refills pipe in $2B biobucks take care of ImmunOnco

.Instil Bio has actually been actually a biotech in search of a pipeline after it scrapped its own l...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back legal rights to a very early Alzheimer's illness system to Denali Therapies,...